Trends in Melanoma Mortality in Serbia: A 22-Year Population-Based Study
- PMID: 39444477
- PMCID: PMC11493581
- DOI: 10.18502/ijph.v53i4.15559
Trends in Melanoma Mortality in Serbia: A 22-Year Population-Based Study
Abstract
Background: We aimed to investigating the sex-specific and age-specific melanoma mortality trends observed on the territory of Serbia between 2000 and 2021.
Methods: This population-based study used data from the Statistical Office of the Republic of Serbia database during the period 2000-2021. The calculation of the gender and age-standardized rates (ASR) was performed. We used a regression analysis complete with linear trend model.
Results: The mean ASR was 1.77 per 100,000 people, meaning that male mortality rates (2.24 per 100,000) was higher than female mortality rates (1.34 per 100,000). During the observation period, a rising trend in mortality from melanoma skin cancer was reported. Observed by gender, the change of melanoma mortality trend was significant in men (P=0.021), but not in women (P=0.747). The annual growth rate of ASRs values was 1.43%. A increase in the melanoma mortality rate was observed since 2000 by 2.44% annually in males and by 2.79% annually in females. Mortality rates were increasing in both sexes as they aged, and the greatest number of deaths was recorded in the group of those aged 80 yr or above (16.25 per 100,000 for men; 10.45 per 100,000 for women).
Conclusion: Our study findings underline the importance of launching more effective public health awareness campaigns to educate people about the dangers of melanoma and its symptoms' detection along with establishing a diagnosis at an early stage of the disease, especially among male patients and those at an advanced age.
Keywords: Age-standardized rates; Malignant melanoma; Mortality; Population-based study.
Copyright© 2024 Babic et al. Published by Tehran University of Medical Sciences.
Figures
Similar articles
-
Mortality of Malignant Melanoma in Central Serbia, in the Period 1999-2015.Dermatol Pract Concept. 2023 Jan 1;13(1):e2023008. doi: 10.5826/dpc.1301a8. Dermatol Pract Concept. 2023. PMID: 36892369 Free PMC article.
-
Mortality trend of cutaneous melanoma in Montenegro from 1990-2018.Eur Rev Med Pharmacol Sci. 2024 May;28(9):3463-3472. doi: 10.26355/eurrev_202405_36192. Eur Rev Med Pharmacol Sci. 2024. PMID: 38766804
-
Italian cancer figures, report 2012: Cancer in children and adolescents.Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225. Epidemiol Prev. 2013. PMID: 23585445 English, Italian.
-
Screening for reducing morbidity and mortality in malignant melanoma.Cochrane Database Syst Rev. 2019 Jun 3;6(6):CD012352. doi: 10.1002/14651858.CD012352.pub2. Cochrane Database Syst Rev. 2019. PMID: 31157404 Free PMC article.
-
[SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].Epidemiol Prev. 2023 Jan-Apr;47(1-2 Suppl 1):1-286. doi: 10.19191/EP23.1-2-S1.003. Epidemiol Prev. 2023. PMID: 36825373 Italian.
Cited by
-
Melanoma Skin Cancer Recognition with a Convolutional Neural Network and Feature Dimensions Reduction with Aquila Optimizer.Diagnostics (Basel). 2025 Mar 18;15(6):761. doi: 10.3390/diagnostics15060761. Diagnostics (Basel). 2025. PMID: 40150103 Free PMC article.
References
-
- Erdmann F, Lortet-Tieulent J, Schüz J, et al. (2013). International trends in the incidence of malignant melanoma 1953–2008--are recent generations at higher or lower risk? Int J Cancer, 132 (2): 385–400. - PubMed
LinkOut - more resources
Full Text Sources